This compound is primarily used in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) for therapeutic drugs. Its structure, featuring a piperidine ring and a trifluoro-hydroxyethyl group, makes it a valuable intermediate in organic synthesis. It is often employed in the production of compounds targeting neurological and psychiatric disorders, such as antidepressants and antipsychotics. Additionally, its tert-butyl carboxylate group provides stability and ease of handling during chemical reactions, making it a preferred choice in multi-step synthetic processes. The trifluoroethyl moiety can enhance the metabolic stability and bioavailability of the final drug molecule, contributing to its efficacy in medicinal applications.